Curcumin-Based Nanomedicines as Cancer Therapeutics

Curcumin-Based Nanomedicines as Cancer Therapeutics

by Amirhossein Sahebkar and Prashant Kesharwani
Epub (Kobo), Epub (Adobe)
Publication Date: 21/02/2024

Share This eBook:

  $213.99

Curcumin-Based Nanomedicines as Cancer Therapeutics presents a consistent and thorough overview of nanocurcumin applications in cancer treatments. It brings together the novel applications of nanocurcumin in biological milieu as well as helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries.Nanocurcumin have been widely explored for treatment of various cancers, however the scientific literature is inconsistent in style and structure and scattered across many sources. By providing an explicit account on vital aspects on nanocurcumin-based anticancer delivery approaches and discussing the perspectives of the technologies explored so far based upon the findings outlined, the book offers updated and in-depth knowledge on the topic in one single source written by global leading experts.In addition, the book aims to stimulate the interest of the academic researchers, industrial scientists, businessmen and young scholars to address key multidisciplinary challenges faced by nanotechnologists to foster the desired collaboration among biologists, chemists, physicists, engineers, and clinicians to find proper and efficient new cancer treatments. - Discusses the complete journey of curcumin delivery from fundamental to most recent anticancer applications using nanotechnology - Provides in-depth knowledge on novel anticancer application of nanocurcumin in biological milieu - Presents reliable and updated information for researchers on nanocurcumin-based anticancer targeted drug delivery

ISBN:
9780443154133
9780443154133
Category:
Enterprise software
Format:
Epub (Kobo), Epub (Adobe)
Publication Date:
21-02-2024
Language:
English
Publisher:
Academic Press

This item is delivered digitally

Reviews

Be the first to review Curcumin-Based Nanomedicines as Cancer Therapeutics.